Background
Atherosclerotic aortic plaque (AAoP) is inversely associated with estimated glomerular filtration rate (eGFR), a commonly used continuous measure of kidney function. We sought to determine whether eGFR stage, categorical stratification by eGFR based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria, is also associated with prevalence and burden of AAoP, as clinically patients are often characterized in terms of eGFR stage.
Methods
We quantified prevalence and burden of AAoP in the abdominal aortas of 1690 adults (65±9y, 53% women) from the Framingham Offspring cohort who underwent cardiovascular magnetic resonance (CMR) and serum creatinine measured at the adjacent cycle exam. Abdominal imaging used a free-breathing, ECG-gated T2W axial black blood sequence with 5-mm slice thickness, 5-mm gap and 1.03x0.64 in-plane resolution. The eGFR was calculated from creatinine using Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi) equations and study participants were stratified by eGFR stage: ≥90, 60-89, <60 ml/min/1.73m 2 . (As few participants had eGFR<60, we combined all of these participants into a single group, whereas KDIGO criteria further stratify patients.) We tested for trends (Cochrane-Armitage test) in prevalence and burden of AAoP by eGFR stage and used multivariable-adjusted logistic (plaque present or absent) and Tobit (plaque volume) regression models to assess association of AAoP with worsening eGFR stage.
Results
Mean eGFR was 84±18 ml/min/1.73m 2 in both sexes. Table 1 shows prevalence and burden of AAoP by sex and eGFR stage. On MV-adjusted logistic regression greater age (odds ratio, OR=1.32/10 years, p<0.0001), fasting glucose (OR=1.10/10mg/dL, p=0.006), pack-years smoked and current smoking (OR=1.66, p=0.007), cholesterol treatment (OR=1.40, p=0.017) and eGFR stage 1 NHLBI's Framingham Heart Study, Newton, MA, USA Full list of author information is available at the end of the article 
Conclusions
In a community-dwelling cohort of middle aged and older aduts, reduced kidney function, as assessed by eGFR and KDIGO stage is associated with greater prevalence of and volume of AAoP, even after adjustment for other cardiovascular disease risk factors.
